| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/06/2015 | US8927573 8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists |
| 01/06/2015 | US8927572 Crystal form I of salt of a dipeptidyl peptidase-IV inhibitor and preparation method and use thereof |
| 01/06/2015 | US8927571 Pyrido[4,3-B]indoles and methods of use |
| 01/06/2015 | US8927570 1-naphthyl-or 1-dihydroacenaphthenyl-pyrido[B]indoles and uses thereof in treating cancers |
| 01/06/2015 | US8927569 Macrocyclic compounds as antiviral agents |
| 01/06/2015 | US8927568 Medicament for the treatment of endometriosis |
| 01/06/2015 | US8927567 Fluoroergoline analogs |
| 01/06/2015 | US8927566 Norepinephrine and selective serotonin receptor blocker and use thereof |
| 01/06/2015 | US8927565 Compositions for veterinary and medical applications |
| 01/06/2015 | US8927564 Synthesis of polycyclic alkaloids |
| 01/06/2015 | US8927563 Kinase inhibitor |
| 01/06/2015 | US8927562 Fused tricyclic inhibitors of mammalian target of rapamycin |
| 01/06/2015 | US8927561 Pyrimidinedione anti-viral compounds |
| 01/06/2015 | US8927560 4-Aza-2, 3-didehydropodophyllotoxin compounds and process for the preparation thereof |
| 01/06/2015 | US8927559 Quinazolinone-type compounds as CRTH2 antagonists |
| 01/06/2015 | US8927558 Methods for detecting and reducing impurities of Lapatinib and salts thereof |
| 01/06/2015 | US8927557 Methylpyrrolopyrimidinecarboxamides |
| 01/06/2015 | US8927556 1H-pyrrolo[3,4-D]pyrimidin-2(6H)-one compounds |
| 01/06/2015 | US8927555 Thieno- and furo-pyrimidine modulators of the histamine H4 receptor |
| 01/06/2015 | US8927554 Hair growth and/or regrowth compositions |
| 01/06/2015 | US8927553 Deuterium-enriched alkyl sulfonamides and uses thereof |
| 01/06/2015 | US8927552 Polymorphic forms of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride |
| 01/06/2015 | US8927551 Isoxazolines as inhibitors of fatty acid amide hydrolase |
| 01/06/2015 | US8927550 Heterocyclic compounds as CCR1 receptor antagonists |
| 01/06/2015 | US8927549 Adamantyl benzamide derivatives |
| 01/06/2015 | US8927548 Triazole compounds that modulate HSP90 activity |
| 01/06/2015 | US8927547 Pyrimidine derivatives |
| 01/06/2015 | US8927546 Therapeutic piperazines |
| 01/06/2015 | US8927545 Inhibiting Eph B-3 kinase |
| 01/06/2015 | US8927543 Dihydropyrimidinoisoquinolinones and pharmaceutical compositions thereof for the treatment of inflammatory disorders |
| 01/06/2015 | US8927542 Bicyclic antibiotics |
| 01/06/2015 | US8927541 Tricyclic antibiotics |
| 01/06/2015 | US8927540 Pyridazinone derivatives |
| 01/06/2015 | US8927539 Cyclic inhibitors of 11β-hydroxysteroid dehydrogenase 1 based on the 1,3-oxazinan-2-one structure |
| 01/06/2015 | US8927537 Patches, formulations, and associated methods for transdermal delivery of alprazolam and other drugs |
| 01/06/2015 | US8927536 Tetrahydrothiazepine derivative |
| 01/06/2015 | US8927535 Cyclopropyl-fused-1,3-thiazepines as BACE1 and/or BACE2 inhibitors |
| 01/06/2015 | US8927533 Thio derivatives bearing lactams as potent HDAC inhibitors and their uses as medicaments |
| 01/06/2015 | US8927532 Therapeutic agent and diagnostic agent for mitochondrial dysfunction brain diseases |
| 01/06/2015 | US8927531 Indanyloxydihydrobenzofuranylacetic acids |
| 01/06/2015 | US8927530 Therapeutic combination comprising a PLK1 inhibitor and an antineoplastic agent |
| 01/06/2015 | US8927529 Treatment of back pain by injection of microparticles of dexamethasone acetate and a polymer |
| 01/06/2015 | US8927528 Composition for treating hearing loss |
| 01/06/2015 | US8927526 Fused aromatic PTP-1B inhibitors |
| 01/06/2015 | US8927524 Sterile alginate-based aqueous composition for medical use and process for the preparation thereof |
| 01/06/2015 | US8927522 Microalgal polysaccharide compositions |
| 01/06/2015 | US8927521 Cyclic adenosine monophosphates for reducing the formation of adhesions |
| 01/06/2015 | US8927520 Antibacterial compounds |
| 01/06/2015 | US8927519 Methods for producing interfering RNA molecules in mammalian cells and therapeutic uses for such molecules |
| 01/06/2015 | US8927516 Combination of DNA repair inhibition with bendamustine or gemcitabine in the treatment of cancer |
| 01/06/2015 | US8927515 Methods and compositions for the specific inhibition of androgen receptor by double-stranded RNA |
| 01/06/2015 | US8927512 RNA aptamer specifically binding to carcinoembryonic antigen and use thereof |
| 01/06/2015 | US8927511 Treatment of vascular endothelial growth factor (VEGF) related diseases by inhibition of natural antisense transcript to VEGF |
| 01/06/2015 | US8927510 Compositions and methods for inhibition of retroviruses |
| 01/06/2015 | US8927509 Aptamer modulators of complement protein C3 and biologically active proteolytic products thereof |
| 01/06/2015 | US8927507 Selective glycosidase inhibitors and uses thereof |
| 01/06/2015 | US8927506 Acetates of 2-deoxy monosaccharides with anticancer activity |
| 01/06/2015 | US8927505 Nutritive compositions and methods of using same |
| 01/06/2015 | US8927504 Combined use of dipeptidyl peptidase 4 inhibitor and sweetener |
| 01/06/2015 | US8927491 Methods for forming compositions for treating joints comprising bone morphogenetic protein and hyaluronic acid |
| 01/06/2015 | US8927490 Systems and methods to estimate nutritional needs of human and other patients |
| 01/06/2015 | US8927487 Antimicrobial cationic peptides and formulations thereof |
| 01/06/2015 | US8927253 Administration of enzyme and prebiotic combinations that enhance probiotic growth and efficacy |
| 01/06/2015 | US8927206 Virus causing respiratory tract illness in susceptible mammals |
| 01/06/2015 | US8927046 Resveratrol compositions |
| 01/06/2015 | US8927033 Hyperlipemia-ameliorating agent, anemia-ameliorating composition, uric-acid-level-reducing composition, and food or beverage |
| 01/06/2015 | US8927032 Methods for treating metabolic disorders |
| 01/06/2015 | US8927031 Anti-glycation methods and compositions |
| 01/06/2015 | US8927028 Pharmaceutical composition containing coated, floating particles |
| 01/06/2015 | US8927026 Shampoo compositions with increased deposition of polyacrylate microcapsules |
| 01/06/2015 | US8927025 Alcohol-resistant metoprolol-containing extended-release oral dosage forms |
| 01/06/2015 | US8927024 Antimicrobial polyanhydride nanoparticles |
| 01/06/2015 | US8927021 Granulating process and thus prepared granulate |
| 01/06/2015 | US8927019 Methods and compositions for treating recurrent cancer |
| 01/06/2015 | US8927018 Immobilized metallic nanoparticles as unique materials for therapeutic and biosensor applications |
| 01/06/2015 | US8927017 Pharmaceutical preparation containing gabapentin |
| 01/06/2015 | US8927013 Misuse preventative, controlled release formulation |
| 01/06/2015 | US8927012 Multi-vitamin and mineral nutritional supplements |
| 01/06/2015 | US8927011 Method for producing pharmaceutical tablet |
| 01/06/2015 | US8927010 Compositions for treatment of attention deficit hyperactivity disorder |
| 01/06/2015 | US8927009 ABT-263 capsule |
| 01/06/2015 | US8927007 Formulations for treatment with glucosinolates |
| 01/06/2015 | US8927006 Methods and compositions for rapid treatment of otitis externa |
| 01/06/2015 | US8927005 Liquid formulations for treatment of diseases or conditions |
| 01/06/2015 | US8926998 Polycarbonates bearing pendant primary amines for medical applications |
| 01/06/2015 | US8926965 Nucleic acid encoding superoxide dismutase variants and methods of use thereof |
| 01/06/2015 | US8926963 Compositions and soft tissue replacement methods |
| 01/06/2015 | US8926953 Method of enhancing hair growth |
| 01/06/2015 | US8926949 Composition for oral health treatment and related methods of use |
| 01/06/2015 | US8926947 Polyol and polyether iron oxide complexes as pharmacological and/or MRI contrast agents |
| 01/06/2015 | US8926946 Peptides for transport of therapeutics and their carriers in mouse models and humans |
| 01/06/2015 | US8926584 Device, system, and method for targeted delivery of anti-inflammatory medicaments to a mammalian subject |
| 01/06/2015 | US8926548 Agent for preventing bleeding from cerebral cortical vein |
| 01/06/2015 | US8926543 Immunoactivation blood perfusion filter for the treatment of malignant tumors |
| 01/06/2015 | US8925493 Hoof bath system |
| 01/06/2015 | CA2781112C Use of alpha 2 adrenergic receptor agonists for treating or preventing psoriasis |
| 01/06/2015 | CA2781041C Spiropiperidine compounds as orl-1 receptor antagonists |
| 01/06/2015 | CA2770411C Aerosol containing a particulate active substance |
| 01/06/2015 | CA2767129C Compositions and methods for silencing apolipoprotein b |
| 01/06/2015 | CA2764425C Trans-4-[[(5s)-5-[[[3,5-bis(trifluoromethyl)phenyl]methyl] (2-methyl-2h-tetrazol-5-yl)amino]-2,3,4,5-tetrahydro-7,9-dimethyl-1h-1-benzazepin-1-yl]methyl]-cyclohexanecarboxylic acid |